Full transcript
0:00Picture this. You're sitting in a clean
0:02office. Diplomas cover the walls. There
0:04is a calm, confident surgeon across the
0:07desk from you. And they look you in the
0:09eye and say, "I think surgery is your
0:11best option." And almost every person in
0:14that chair does the same thing. They
0:15nod. They don't ask what happens if they
0:18say no. They don't ask whether there's
0:20another path. They don't ask how many
0:22times this surgeon has performed this
0:24specific procedure on someone their age
0:26with their health history. They trust
0:28the white coat in the room and they
0:30sign. Now, I want to be honest with you
0:33right away. That trust is often
0:35completely justified. Surgery saves
0:38lives. Real lives. People who walk back
0:41into their lives better, stronger, freer
0:43from pain because of an operation they
0:46needed. But here is the thing I have
0:48seen over and over that the brochures
0:50and consent forms almost never show you.
0:53For adults over 60, some of the most
0:55commonly recommended surgeries carry
0:58risks that compound dramatically with
1:00age. Risks that are statistically
1:02documented, clinically significant, and
1:05routinely underexplained in a 15-minute
1:08consultation. And in many of these
1:10cases, there are alternatives, real
1:12evidence-based alternatives that nobody
1:14bothered to put on the table. My name is
1:16Dr. Elias and this channel is dedicated
1:18to senior health education, helping
1:20older adults understand the research
1:22behind the medical decisions they face
1:24every day. Today, I'm going to walk you
1:27through five surgeries that are
1:28frequently recommended to people over
1:3060, tell you the truth about their real
1:33risk profiles, and give you the specific
1:35questions you need to ask before you
1:38ever agree to go under the knife. Stay
1:40with me to the end because the last
1:42thing I share a simple forward question
1:45has the potential to change the entire
1:47trajectory of a surgical conversation
1:49and you've probably never heard it
1:50before. Before we move on, drop your
1:52name and your age in the comments. I'd
1:54love to know who I'm talking to today.
1:56Let's begin. Surgery one, corateed
1:59endardctomy. Every year, hundreds of
2:02thousands of seniors are told that they
2:04have narrowing in the arteries in their
2:06neck, the corateed arteries, and that
2:08this narrowing puts them at risk for
2:10stroke. And then they're told surgery
2:12can fix this. The operation is called a
2:14corateed endardctomy.
2:16The surgeon opens the artery in your
2:18neck, physically removes the plaque
2:20buildup inside the vessel wall, and
2:22closes it back up. In the right patient,
2:25under the right circumstances, this
2:27procedure does exactly what it promises.
2:30It reduces stroke risk. But here is
2:32where it gets complicated. And this is
2:34the part that most people sitting in
2:36those consultations never hear. The
2:38benefit of this surgery depends almost
2:40entirely on whether you've already had
2:42symptoms. This distinction is
2:45everything. If you've had a transient
2:47eskeemic attack, sometimes called a
2:49minstroke involving sudden arm weakness,
2:52slurred speech, or temporary vision loss
2:55that resolved within 24 hours, and your
2:57kurateed is more than 70% blocked. The
3:00evidence from a landmark study called
3:01the NASCAT trial strongly supports
3:04surgery. published in the New England
3:06Journal of Medicine in 1991. That
3:08research showed a meaningful significant
3:11reduction in subsequent stroke risk for
3:13symptomatic patients with severe
3:15stenosis. In that population, surgery
3:18does what it promises. But what if you
3:21haven't had symptoms? What if a routine
3:23ultrasound just found narrowing and
3:25suddenly there's a surgical
3:26recommendation on the table? Here is
3:28where the research becomes genuinely
3:30sobering. For asymptomatic patients,
3:33people who feel completely fine, the
3:35asymptomatic corateed surgery trial
3:37known as ACST1 published in the Lancet
3:40in 2004 found that the absolute risk
3:43reduction from surgery while
3:45statistically real requires careful
3:47reading. The 5-year gross reduction in
3:50stroke risk was about 5.4 percentage
3:53points. But the surgery itself carries a
3:56peroperative cost that directly offsets
3:59that number. The ACST1 trial reported
4:02that the peroperative stroke and death
4:04rate in the surgery group was
4:05approximately 3.1%.
4:07And that was across expert centers
4:09participating in a controlled clinical
4:11trial. In routine community hospitals,
4:14published research by Dr. John
4:16Burkemeyer and colleagues in the New
4:18England Journal of Medicine demonstrated
4:20that complication rates for corateed
4:22surgery climb measurably higher at lower
4:25volume centers. So let me translate that
4:28into plain language. The surgery carries
4:31roughly a 3% risk of causing the very
4:34event it's designed to prevent on the
4:36day of the procedure itself. When you
4:38subtract that perioperative cost from
4:40the gross 5-year benefit, the net
4:43advantage for an asymptomatic patient,
4:45particularly outside of an expert
4:47surgical center, can become very small
4:50indeed. And here is something that has
4:52changed significantly in recent years
4:54that most patients never hear in a
4:56surgical consultation. Modern
4:58non-surgical management of corateed
5:00artery disease has advanced
5:02substantially. Highintensity statin
5:04therapy, optimized blood pressure
5:06control, and anti-platlet medications
5:08like aspirin or clipidigil have been
5:11shown to meaningfully reduce stroke risk
5:13in patients who are properly managed.
5:15For many asymptomatic seniors,
5:17particularly those with other conditions
5:19that elevate surgical risk. This medical
5:22therapy route is now considered a
5:23genuinely comparable strategy. I'm not
5:26telling you to refuse this surgery. I am
5:28telling you to ask this and write it
5:30down. Am I symptomatic or asymptomatic?
5:34And what is the peroperative
5:35complication rate at this specific
5:37hospital for this specific procedure? A
5:40confident experienced vascular surgeon
5:42will answer both parts of that question
5:44directly. If either part creates visible
5:47discomfort or evasion, that is critical
5:50information worth acting on. Surgery
5:52two, spinal cord stimulator
5:55implantation. Chronic back pain and
5:58nerve pain in the legs is one of the
6:00most debilitating conditions that
6:02shadows people through their 60s,7s and
6:05beyond. If you've been living with it,
6:07you know what it does to your sleep,
6:08your mood, your independence, your sense
6:11of who you are. And when the injections
6:14stop working and physical therapy feels
6:16like running in place, a new option gets
6:18introduced. A spinal cord stimulator.
6:22Electrodes placed near your spinal cord.
6:24A small battery powered generator
6:26implanted under the skin of your back or
6:29abdomen. Electrical pulses precisely
6:32calibrated designed to interrupt the
6:34pain signals before they reach your
6:36brain. No more opioids. No repeated
6:39injections. Just a device that keeps
6:41working while you live your life. And
6:43for some patients, it genuinely helps. I
6:45won't pretend otherwise. But here is
6:48what the clinic brochures and the
6:5020inute implanting physician
6:52consultation often leave out when it
6:54comes to elderly patients. This is a
6:56medical device, a sophisticated
6:58batterypowered device implanted into a
7:01human body that is moving, aging, and
7:03changing every day. And like all
7:05implanted devices, it fails. The
7:08American Society of Regional Anesthesia
7:10reviewing the published literature
7:12reports that complications from spinal
7:14cord stimulators, including lead
7:16migration, lead fracture, device
7:19malfunction, and battery failure
7:21requiring replacement, are estimated to
7:23range from 20 to 40% over the devices
7:26lifetime. That range applies to older
7:29generation devices. More modern systems
7:31show lower rates, though long-term data
7:34beyond three years remains limited for
7:36the newest technology. A meaningful
7:39percentage of seniors who receive this
7:40device will need at least one additional
7:42procedure to address a hardware problem.
7:45For an elderly body, every additional
7:47surgical procedure adds cumulative
7:49stress to systems that may already be
7:51operating with reduced capacity. Any
7:54implanted foreign object creates a
7:56colonization risk. Infection at the
7:59implant site, while not the majority of
8:01cases, can be serious and difficult to
8:04treat, particularly in elderly patients
8:06with diabetes, compromised immunity, or
8:08reduced circulation. When an infected
8:11device requires removal, that is another
8:13surgery. And post removal, the patient
8:15is left without the pain management they
8:17had come to rely on. The long-term data
8:20on spinal cord stimulators, particularly
8:22for the most common indication in
8:24elderly patients, failed back surgery
8:27syndrome, shows highly variable
8:29outcomes. Two patients with nearly
8:32identical diagnoses can have
8:33dramatically different responses to the
8:36same device. And the current science
8:38cannot reliably predict which category
8:40you'll be in before the implantation
8:42happens. Here is the part I want you to
8:44hear most carefully. In many cases, a
8:47spinal cord stimulator is being
8:49recommended because a previous spinal
8:51surgery didn't work. You had the fusion,
8:53the decompression, the hardware and the
8:56pain is still there or it changed or
8:58it's worse. Now, a device is being
9:01offered as a solution to the problem the
9:03earlier surgery created. If that's your
9:06situation, you are being asked to
9:08respond to a complication with another
9:11procedure. The crucial question to ask
9:13is what does the evidence show not just
9:16immediately after implantation but at
9:19two years and five years for someone
9:21with my specific diagnosis and age
9:23profile. Early postimplantation results
9:26are when patients feel most hopeful.
9:29Long-term is where the real picture
9:31lives. There are also non-implant
9:34alternatives deserving serious
9:36discussion. structured interdisciplinary
9:39pain rehabilitation programs, radio
9:42frequency ablation for specific
9:44identifiable pain generators, and pain
9:47neuroscience education combined with
9:49targeted physical therapy. These
9:51approaches don't make the news, but for
9:54many seniors, they offer meaningful
9:56quality of life improvement without
9:58putting a permanent device in the spine.
10:01If you're still watching and this is
10:02helping you, type the number two in the
10:04comments so I know you're here with me.
10:07Surgery three, radical prostatctomy in
10:10elderly men. This section is for every
10:13man over 60 watching this and for every
10:15woman who loves one. The moment a doctor
10:17says prostate cancer, something happens
10:20in the room. The air changes. The
10:22instinct kicks in immediately and
10:24powerfully. Take it out. Remove it. Get
10:27rid of it. I understand that the word
10:29cancer carries weight that few other
10:31words in medicine carry. And I will
10:34never dismiss the fear that comes with
10:35hearing it. But here is what the
10:37research specifically two landmark
10:39trials that followed men for nearly two
10:41decades actually found about elderly men
10:44with low to intermediate grade localized
10:47prostate cancer. The Peote trial
10:50published in the New England Journal of
10:51Medicine in 2012 followed 731 men for
10:56over a decade. Half received radical
10:59prostatctomy, full surgical removal of
11:01the prostate gland. Half were managed
11:04with careful observation. The result in
11:06men with low-risk prostate cancer,
11:09surgery provided no statistically
11:11significant reduction in overall
11:12mortality or prostate cancer specific
11:15mortality compared to watchful waiting.
11:17And that finding held across time. In
11:202017, the same research team published
11:23an updated follow-up in the New England
11:25Journal of Medicine. This time covering
11:27nearly 20 years of data on the same men.
11:30The conclusion was the same. After
11:32nearly 20 years, surgery was not
11:34associated with significantly lower all
11:37cause or prostate cancer mortality than
11:39observation. where a benefit of surgery
11:42appeared at all in longer followup. It
11:44was concentrated in men with
11:46intermediate and higher risk cancer, not
11:48in the low-risisk group most commonly
11:50diagnosed through routine PSA screening.
11:52Then came the Protectee trial in 2016,
11:55which followed over 1,600 men for 10
11:57years across three groups, active
12:00monitoring, radical prostatctomy, and
12:02radiation. Prostate cancer mortality at
12:0510 years was approximately 1% across all
12:08three groups. The differences between
12:11groups were not statistically
12:12significant. And yet surgery carries
12:15consequences that monitoring does not.
12:18Urinary incontinence following radical
12:20prostatctomy is well documented. The
12:23Protectee trial showed that at 6 months
12:26postsurgery, nearly half of the surgery
12:28patients reported using absorbent pads
12:31daily compared to a small fraction of
12:34the active monitoring group. At 12
12:36months, rates improve, but clinically
12:39significant persistent incontinence at
12:41one year is estimated between 10 and 30%
12:44depending on surgical technique and
12:45patient age. Early rates are
12:48substantially higher. Erectile
12:50dysfunction in men over 65 following
12:52prostatctomy is even more prevalent
12:55across multiple studies. For a
12:5772year-old man, these are not minor
13:00footnotes in a consent form. They
13:02represent a fundamental daily change in
13:04how he experiences his body and his
13:06life. Here is the misconception I want
13:08to correct directly. Active surveillance
13:11is not giving up. It is a structured
13:13evidence-based clinical protocol
13:15involving regular PSA testing, periodic
13:18biopsies, MRI imaging, and clearly
13:21defined criteria for when treatment
13:23becomes necessary. Many men on active
13:25surveillance never require surgery or
13:27radiation at all. Others move to
13:29treatment when the data shows
13:31progression and by then the decision is
13:33far better informed than it was at
13:35diagnosis. The prostate cancer
13:37conversation is not surgery versus
13:40surrender. If you or someone you love
13:42receives a prostate cancer diagnosis,
13:45please ask this question directly based
13:48on my Gleason score, my PSA trajectory,
13:51and my overall health. Am I a candidate
13:54for active surveillance? And what would
13:56that monitoring protocol actually look
13:58like? Prostate cancer in elderly men,
14:01particularly low and intermediate grade,
14:03grows slowly. A calm, informed decision
14:06almost always serves better than a fast
14:08one. Do not let urgency be manufactured
14:11where the biology does not require it.
14:13If this is the kind of information you
14:15want before a doctor's appointment, not
14:18after, subscribe and hit the bell. Every
14:21day I break down exactly what the
14:23research says in plain language so you
14:26walk in informed. Surgery 4,
14:29simultaneous bilateral joint
14:31replacement. Let me say something
14:33clearly before this section begins. Hip
14:36and knee replacements done thoughtfully
14:38and one at a time are among the most
14:41genuinely successful surgeries in the
14:44history of modern medicine. The right
14:46patient, the right timing, the right
14:47rehabilitation, and the outcome is a
14:50person who moves freely, sleeps without
14:52pain, and keeps living the life they
14:54love. That isn't in question. What is in
14:57question is a specific version of this
15:00surgery that's becoming more common in
15:02busy orthopedic centers. A version that
15:04has a logical appeal on the surface and
15:07a hidden cost underneath it.
15:09Simultaneous bilateral joint
15:11replacement, both knees or both hips in
15:13one operating room under one anesthetic
15:16event in one hospitalization. The pitch
15:19makes intuitive sense. One anesthesia
15:21instead of two, one recovery instead of
15:24two. Get it all done and move forward.
15:27For a 74 year old patient with
15:29hypertension, type 2 diabetes, and any
15:31degree of cardiovascular disease, the
15:33arithmetic changes completely. Here is
15:36why. Blood loss in simultaneous
15:38bilateral joint replacement is
15:40substantially higher than in stage
15:42procedures, operations done months
15:44apart. For an elderly body managing
15:46cardiovascular disease or any degree of
15:49anemia, that additional blood loss isn't
15:51just an inconvenience. It places
15:54simultaneous strain on the heart,
15:56kidneys, and circulatory system at the
15:59exact moment they're already responding
16:01to anesthesia and surgical trauma. The
16:04clotting risk compounds this. Deep vein
16:08thrombosis clots forming in the legs and
16:10pulmonary embolism when those clots
16:12travel to the lungs are consistently
16:14elevated in bilateral procedures
16:16compared to single joint operations. A
16:19study by Meudus and colleagues analyzing
16:21over four million total knee
16:23arthroplasty discharges and published in
16:25clinical orthopedics and related
16:27research showed that bilateral
16:29procedures carried higher inhosp
16:31complications and mortality compared to
16:34unilateral procedures with the risk most
16:36pronounced in patients with pre-existing
16:39coorbidities. A separate journal of
16:41arthroplasty study confirmed that the
16:43bilateral group showed a 2.1 times
16:46greater overall complication rate and
16:48patients over 70 exhibited significantly
16:51higher complication rates than younger
16:54patients undergoing the same bilateral
16:56approach. Now it's worth being precise
16:59here. In lower risk patients without
17:01significant coorbidities, large-scale
17:04analyses show the mortality gap between
17:06bilateral and unilateral procedures
17:09narrows considerably. The concern is
17:11specifically for elderly patients who
17:13carry coorbidities. And that is exactly
17:16the population most often facing joint
17:19replacement decisions. And here's
17:21something almost nobody discusses at the
17:23consent stage. Rehabilitation capacity.
17:26After bilateral joint replacement, both
17:29legs are affected simultaneously. Both
17:31hurt, both need support, both are being
17:34rehabilitated at the same time. For a
17:37patient who lives alone, has limited
17:39family support nearby, or has any
17:41cognitive vulnerability, the
17:43rehabilitation environment after
17:44bilateral surgery can become genuinely
17:47hazardous, increasing fall risk,
17:49pressure injury risk, and the
17:51probability of hospital readmission.
17:54Before agreeing to bilateral joint
17:56replacement in a single procedure, I
17:58want you to ask three specific
18:00questions. What does the complication
18:02data show for bilateral versus stage
18:05procedures in patients over 70 with my
18:08specific health conditions? What is the
18:10realistic rehabilitation plan? Not the
18:13generic plan, but the actual plan given
18:15where I live and who will be available
18:17to help me. What are the risks and
18:19benefits of staging these procedures 6
18:21months apart specifically for my body?
18:24You may still choose bilateral surgery,
18:27but that choice should be yours made
18:28with full information, not made by
18:31default. If you've made it this far and
18:33you're getting value from this, type the
18:35number four in the comments so I know
18:37you're here with me. Surgery five, EVAR
18:41versus open aortic repair. Short-term
18:43safety versus long-term commitment. An
18:45abdominal aortic aneurysm, a bulge in
18:47the body's main artery, is one of the
18:49most serious vascular diagnoses a person
18:51can receive. If a large aneurysm
18:54ruptures, the mortality rate is
18:55catastrophic. Surgery to prevent
18:57rupture. In the right patient at the
18:59right time genuinely saves lives. But
19:02within this condition lives a decision
19:04point that affects outcomes in ways most
19:06patients are never fully told about.
19:08There are two ways to repair an aortic
19:10aneurysm. And the difference between
19:12them is not simply cosmetic. One
19:14procedure opens your entire abdomen and
19:17takes weeks to recover from. The other
19:20goes in through small incisions in the
19:21groin and sends you home in days. The
19:24EVAR trial 1, whose 30-day results were
19:26published in the Lancet in 2004,
19:29demonstrated that EVAR carried
19:31dramatically lower short-term mortality,
19:331.7% compared to 4.7% for open repair.
19:37that early survival advantage is real
19:40and it matters enormously for any
19:42elderly patient about to enter an
19:44operating room. But here is the part
19:45that the clinic brochure for
19:47endovvascular repair very rarely shows
19:50you. The 15-year follow-up of that same
19:52EVAR trial one published in the Lancet
19:55in 2016 arrived at a conclusion that
19:58fundamentally changes how we should talk
20:00about this procedure. While EVAR carries
20:03a clear early survival benefit, the
20:05researchers found it carries an inferior
20:07late survival compared to open repair
20:10beyond approximately eight years. After
20:12that point, aneurysm related mortality
20:15was actually higher in the EVAR group
20:17driven primarily by secondary sac
20:20rupture in patients whose device had
20:22developed endolaks over time. A
20:24systematic review published in 2019
20:27confirmed this finding across multiple
20:30studies. EVAR is associated with higher
20:32long-term all cause mortality, higher
20:35reintervention rates, and higher
20:37secondary rupture rates compared to open
20:40repair over the long term. So, which
20:42approach is right? This is where age and
20:45life expectancy genuinely matter in the
20:47calculation and where the conversation
20:49needs to become very specific to you.
20:52For an elderly patient in their late 70s
20:54or 80s with other health conditions,
20:57EVAR's powerful short-term advantage is
20:59likely the most clinically relevant
21:01factor. The 8-year crossover point where
21:04open repair begins to show better
21:06long-term survival may not be the
21:08primary concern for a patient whose most
21:10immediate risk is surviving the
21:11operation itself. EVAR gets them through
21:14the repair with far less physiological
21:17burden, and that matters. For a patient
21:20in their mid to late 60 seconds who may
21:22realistically live another 20 years, the
21:25long-term durability picture favors open
21:28repair, provided they can tolerate the
21:31operative burden and have the reserve to
21:33recover from it. And critically, EVAR is
21:36not a one-time fix and walk away. It
21:38requires lifelong surveillance through
21:41annual imaging to detect endolaks and
21:43device complications. That commitment to
21:46ongoing monitoring is not optional. It
21:49is essential and must be clearly
21:51understood before choosing this path.
21:54The question to ask your vascular
21:56surgeon is not simply can I have EVAR
21:58instead of open surgery. The right
22:01question is given my age, my life
22:03expectancy, and my ability to tolerate
22:06each approach, which procedures risk
22:08profile is actually better matched to my
22:11situation. And what does the long-term
22:13surveillance commitment for EVAR look
22:15like in practice? One more thing on
22:17this, not every diagnosed aneurysm
22:20requires immediate intervention. Current
22:23clinical guidelines generally recommend
22:26repair when an abdominal aortic aneurysm
22:28reaches or exceeds 5.5 cm in diameter.
22:32Below that threshold in most patients,
22:34regular ultrasound surveillance every 6
22:37to 12 months combined with blood
22:38pressure optimization is the appropriate
22:40strategy. If you have been diagnosed
22:43with an aneurysm under 5 cm and surgery
22:45is being recommended urgently, ask
22:47clearly what specific characteristic
22:49puts you in a different category. That
22:52answer should be specific, not general.
22:54If you have a parent, a spouse, a
22:56sibling, or a close friend who is facing
22:59any kind of surgical decision right now,
23:02please share this video with them before
23:04that consultation happens. Not after,
23:06before. 5 minutes of the right
23:08information at the right moment can
23:10change everything about that
23:12conversation. We've covered five
23:14surgeries. Now, let's talk about how you
23:17actually use this information. Because
23:19knowledge that stays in your head
23:21doesn't protect you. Knowledge that you
23:23walk into a consultation with written
23:25down ready to ask does. Before any major
23:28surgery, here are four questions I want
23:31you to ask every single time. Question
23:34one, what happens if I don't have this
23:36surgery in the next 6 months? This is
23:39the most important question that most
23:41patients never ask. A good surgeon, a
23:44confident, honest surgeon will give you
23:46a specific, clear answer. If the answer
23:49is that nothing becomes medically urgent
23:51in the near term, you have time. Time to
23:54get a second opinion, time to explore
23:56alternatives, time to optimize your
23:58health before any procedure. If a
24:01surgeon seems visibly uncomfortable with
24:03this question, that discomfort is itself
24:05important data. Question two, is there a
24:08less invasive or non-surgical
24:10alternative? And what does the evidence
24:13show for someone my age specifically?
24:15Note the second part. You're not asking
24:18whether alternatives exist in theory.
24:20You're asking about the evidence for
24:22your demographic, your age group, your
24:24health profile. The answer for a
24:2645year-old and a 75year-old are
24:29frequently different and you deserve the
24:31age appropriate answer. Question three,
24:35what does realistic recovery look like
24:37for someone with my health conditions
24:39and my living situation? Not the
24:41textbook recovery, not the brochure
24:43recovery, yours. If you live alone, what
24:47support will you realistically need and
24:49for how long? If that conversation
24:51hasn't happened yet, start it yourself.
24:54Question four, and this is the one most
24:56people skip. What is your personal
24:58outcome data for this specific procedure
25:00in patients over 70? Four words to lead
25:03with. What are your numbers? Surgeons
25:06track their outcomes. High volume,
25:08experienced surgeons know their personal
25:10complication rates and will give them to
25:12you without hesitation. If that question
25:14is met with deflection, vagueness, or
25:16visible discomfort, seek a second
25:18opinion before signing anything. You are
25:21not being difficult when you ask these
25:23questions. You are being exactly the
25:25kind of engaged, informed patient that
25:28good medicine depends on. I want to tell
25:31you about a patient. I'll call him
25:33Raymond. Raymond was 74 years old,
25:36retired, sharp, the kind of man who
25:40still read the newspaper front to back
25:42every morning, and had opinions about
25:44all of it. He came to me after a routine
25:46corateed ultrasound showed 65% narrowing
25:50in one of his neck arteries. No
25:52symptoms, no thanks in advance, no
25:54episodes, nothing, just a number on a
25:56scan. But the referral letter from his
25:58primary physician was direct. vascular
26:01surgery consultation recommended. When
26:04Raymond sat across from me, he had
26:06printed out three papers from
26:08peer-reviewed journals. He had
26:10highlighted them. He asked if we could
26:12go through them together. We spent 45
26:15minutes in that room. We reviewed his
26:17specific situation, his asymptomatic
26:19status, his excellent cardiovascular
26:22risk management, his surgical risk
26:24profile given his kidney function and
26:26current medications. And together, based
26:28on the evidence, we concluded that
26:30optimizing his medical therapy was the
26:32appropriate path for his specific
26:34profile, we adjusted his statin, refined
26:37his blood pressure management, and
26:39reinforced lifestyle habits he already
26:41maintained well. That was 6 years ago.
26:44Raymond sends me notes occasionally.
26:46Last year, he wrote to tell me he had
26:48finally finished a memoir he'd been
26:50working on for nearly a decade. He said
26:52something I've thought about many times
26:54since. You didn't give me surgery. You
26:57gave me time and I used every bit of it.
27:00That is what informed medicine looks
27:01like. Not medicine that reflexively
27:04avoids the operating room. Not medicine
27:06that reflexively runs toward it either.
27:10Medicine that stops, asks the right
27:12questions, looks at the whole person,
27:14and chooses the path that is actually
27:16right for this specific human being at
27:19this specific moment in their life. A
27:21surgical recommendation is not a
27:23verdict. It is not a test of how
27:25seriously you take your health. It is
27:27the beginning of a conversation and you
27:30have every right to be an active,
27:31questioning, unhurried participant in
27:33that conversation. You hold more power
27:36in that consultation room than most
27:37patients ever realize. Use it. Let me
27:40bring it all together. None of this
27:42means avoid surgery. It means be the
27:45most informed person in that
27:47consultation room. Ask the hard
27:49questions. Request the evidence. seek a
27:52second opinion when your instinct says
27:53something isn't complete. Your age is
27:56not a weakness. Your questions are not
27:58an inconvenience. Your full honest
28:01participation in medical decisions is
28:03not optional. It is essential. Now,
28:06everything I've shared today is general
28:09educational information based on
28:11published medical research and
28:13preventive health principles. It is not
28:15personal medical advice, and it was
28:17never meant to be. Every person's
28:20situation is unique. Before making any
28:22decision about surgery or treatment,
28:24please have a thorough, direct
28:26conversation with your own doctor or
28:28specialist. They know your history. They
28:30know your body. And that conversation,
28:32informed, unhurried, and honest, is
28:34exactly where good medicine begins. If
28:37this video gave you one question you'll
28:39actually ask, or one conversation you'll
28:41actually have, share it with someone you
28:43care about. That share might matter more
28:45than you know. Take care of yourselves.
28:48Stay curious and I'll see you in the
28:50next one.